Enteris BioPharma Highlights 2021 Achievements and 2022 Outlook

BOONTON, N.J., Jan. 5, 2022 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidiary of SWK Holdings Corporation (Nasdaq: SWKH), provided a review of its 2021 business...